Prognostic factors identified in mucoepidermoid carcinoma

Prognostic factors identified in mucoepidermoid carcinoma
Diagnosis of low- or intermediate-grade tumors is associated with significantly better overall survival and disease-free survival in patients with mucoepidermoid carcinoma of the salivary glands, while advanced disease stage and perineural invasion are the most significant indicators of poor prognosis, according to a study published in the Aug. 15 issue of Cancer.

(HealthDay) -- Diagnosis of low- or intermediate-grade tumors is associated with significantly better overall survival and disease-free survival in patients with mucoepidermoid carcinoma (MEC) of the salivary glands, while advanced disease stage and perineural invasion are the most significant indicators of poor prognosis, according to a study published in the Aug. 15 issue of Cancer.

Catherine H. McHugh, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues retrospectively reviewed clinical data from 125 patients with MEC from 1990 to 2007.

The researchers found that, for all patients, the five-year overall survival was 79.3 percent and the disease-free survival was 76.5 percent. Low- and intermediate-grade disease correlated with significantly better overall and disease-free survival than high-grade disease, with no difference noted in between low- and intermediate-grade disease. Indicators of included pathologic results of positive lymph nodes, extracapsular lymph node spread, and perineural invasion. Advanced disease stage and perineural invasion were found to be the most significant on multivariate analysis.

"High histological grade, advanced stage, perineural invasion, positive surgical margins, and submandibular location all portend for unfavorable outcomes among patients with MEC," the authors write. "These factors should therefore be taken into consideration when establishing the aggressiveness of a treatment strategy."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Early response is an indicator for rectal cancer survival

date Apr 10, 2012

(HealthDay) -- In patients with locally advanced rectal cancer undergoing radical resection, response to neoadjuvant chemoradiotherapy is an early marker that correlates with rates of recurrence-free survival, ...

Recommended for you

Breast cancer is not one disease, experts say

date 7 hours ago

(HealthDay)—Breast cancer isn't the same for every woman, even at the cellular level, according to a new statement from four major medical groups focused on the disease.

Teens with breast lumps may be able to avoid invasive biopsy

date 9 hours ago

If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.